160 related articles for article (PubMed ID: 37547718)
1. Expression and correlation of COX-2 and NUCB1 in colorectal adenocarcinoma.
Zhang Y; Zhang G; Zhong J; Li A; Wu Y; Guo Z
PeerJ; 2023; 11():e15774. PubMed ID: 37547718
[TBL] [Abstract][Full Text] [Related]
2. Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients.
Negi RR; Rana SV; Gupta V; Gupta R; Chadha VD; Prasad KK; Dhawan DK
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1675-1681. PubMed ID: 31244287
[TBL] [Abstract][Full Text] [Related]
3. Effects of feeding status on nucb1 and nucb2A mRNA expression in the hypothalamus of Schizothorax davidi.
Yuan D; Zhang X; Wang B; Tang T; Lei L; Deng X; Zhou C; Li Z
Fish Physiol Biochem; 2020 Jun; 46(3):1139-1154. PubMed ID: 32130563
[TBL] [Abstract][Full Text] [Related]
4. Correlation of COX- 2 Expression in Colorectal Carcinoma with Clinicopathological Features.
Venkatachala S; Rajendran M
Turk Patoloji Derg; 2017; 33(3):228-234. PubMed ID: 28272681
[TBL] [Abstract][Full Text] [Related]
5. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication].
Yao HB; Wu AG; Chen YJ; Tang BH
Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1524-8. PubMed ID: 16361154
[TBL] [Abstract][Full Text] [Related]
6. Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: association with clinicopathological parameters.
Wu CY; Lee WH; Wang JY; Chiang H; Chang JL; Tsai WC; Sheu LF; Jin JS
Chin J Physiol; 2006 Dec; 49(6):298-304. PubMed ID: 17357536
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma.
Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Frikha F; Kallel L; Amouri A; Frikha M; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Tumour Biol; 2010 Oct; 31(5):503-11. PubMed ID: 20571967
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between Stat3 signal transduction pathway and expression of cyclooxygenase-2 in colorectal cancer cells].
Zhang H; Wang S; Zhang YC; Ye YJ; Cui ZR; Fang WG
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(41):2899-904. PubMed ID: 16324362
[TBL] [Abstract][Full Text] [Related]
9. Correlation of COX-2 and MMP-13 expressions with gastric cancer and their effects on prognosis.
Ren J; Liu J; Sui X
J BUON; 2019; 24(1):187-193. PubMed ID: 30941969
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclooxygenase-2 (COX-2) in colorectal adenocarcinoma: an immunohistochemical and histopathological study.
Mahmoud AS; Umair A; Azzeghaiby SN; Alqahtani FH; Hanouneh S; Tarakji B
Asian Pac J Cancer Prev; 2014; 15(16):6787-90. PubMed ID: 25169526
[TBL] [Abstract][Full Text] [Related]
11. SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer.
Terrin L; Agostini M; Ruvoletto M; Martini A; Pucciarelli S; Bedin C; Nitti D; Pontisso P
Oncotarget; 2017 Feb; 8(9):15732-15743. PubMed ID: 28178650
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclooxygenase-2 protein in colorectal carcinomas.
Joo YE; Kim HS; Min SW; Lee WS; Park CH; Park CS; Choi SK; Rew JS; Kim SJ
Int J Gastrointest Cancer; 2002; 31(1-3):147-54. PubMed ID: 12622426
[TBL] [Abstract][Full Text] [Related]
13. Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis.
Wu AW; Gu J; Ji JF; Li ZF; Xu GW
World J Gastroenterol; 2003 Sep; 9(9):1990-4. PubMed ID: 12970891
[TBL] [Abstract][Full Text] [Related]
14. RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma.
Shyu RY; Jiang SY; Chou JM; Shih YL; Lee MS; Yu JC; Chao PC; Hsu YJ; Jao SW
Br J Cancer; 2003 Jul; 89(1):146-51. PubMed ID: 12838316
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma.
Ben Ayed-Guerfali D; Charfi S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Cancer Biomark; 2016 Jun; 17(1):67-73. PubMed ID: 27314294
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance.
Xiong B; Sun TJ; Hu WD; Cheng FL; Mao M; Zhou YF
World J Gastroenterol; 2005 Feb; 11(8):1105-8. PubMed ID: 15754389
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclooxygenase 2 and vascular endothelial growth factor in gastric carcinoma: Relationship with clinicopathological parameters.
Hafez NH; Tahoun NS
J Egypt Natl Canc Inst; 2016 Sep; 28(3):149-56. PubMed ID: 27342370
[TBL] [Abstract][Full Text] [Related]
18. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
[TBL] [Abstract][Full Text] [Related]
19. Expression of Ang-2/Tie-2 and PI3K/AKT in colorectal cancer.
Zhang JH; Wang LH; Li XJ; Wang AP; Reng LQ; Xia FG; Yang ZP; Jiang J; Wang XD; Wen CY
Asian Pac J Cancer Prev; 2014; 15(20):8651-6. PubMed ID: 25374184
[TBL] [Abstract][Full Text] [Related]
20. NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolded Protein Response.
Hua YQ; Zhang K; Sheng J; Ning ZY; Li Y; Shi WD; Liu LM
Front Cell Dev Biol; 2021; 9():641836. PubMed ID: 33855021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
